CTLA4 and cancer: Furthermore, the identification of immune checkpoint proteins like CTLA-4 and PD-1 unveiled critical pathways by which cancer cells evade immune surveillance, and the development of immune checkpoint inhibitors revolutionized cancer treatment paradigms.